Ad is loading...
ALNY
Price
$246.80
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
76 days until earnings call
GHRS
Price
$9.62
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
97 days until earnings call
Ad is loading...

ALNY vs GHRS

Header iconALNY vs GHRS Comparison
Open Charts ALNY vs GHRSBanner chart's image
Alnylam Pharmaceuticals
Price$246.80
Change-$0.00 (-0.00%)
Volume$687.27K
CapitalizationN/A
GH Research
Price$9.62
Change-$0.00 (-0.00%)
Volume$103.74K
CapitalizationN/A
ALNY vs GHRS Comparison Chart
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALNY vs. GHRS commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongSell and GHRS is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ALNY: $246.80 vs. GHRS: $9.62)
Brand notoriety: ALNY and GHRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 82% vs. GHRS: 157%
Market capitalization -- ALNY: $32.09B vs. GHRS: $500.51M
ALNY [@Biotechnology] is valued at $32.09B. GHRS’s [@Biotechnology] market capitalization is $500.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileGHRS’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • GHRS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALNY and GHRS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while GHRS’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 6 bearish.
  • GHRS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GHRS is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -4.31% price change this week, while GHRS (@Biotechnology) price change was +7.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 06, 2025.

GHRS is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($31.6B) has a higher market cap than GHRS($482M). GHRS YTD gains are higher at: 65.862 vs. ALNY (28.938). GHRS has higher annual earnings (EBITDA): -41.07M vs. ALNY (-85.69M). ALNY has more cash in the bank: 2.78B vs. GHRS (150M). GHRS has less debt than ALNY: GHRS (733K) vs ALNY (1.3B). ALNY has higher revenues than GHRS: ALNY (2.1B) vs GHRS (0).
ALNYGHRSALNY / GHRS
Capitalization31.6B482M6,556%
EBITDA-85.69M-41.07M209%
Gain YTD28.93865.86244%
P/E RatioN/AN/A-
Revenue2.1B0-
Total Cash2.78B150M1,853%
Total Debt1.3B733K177,626%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYGHRS
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
Declines
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STSOX44.590.78
+1.78%
Sterling Capital SmCp Val C
PGRSX9.830.03
+0.31%
Principal Global Real Estate Sec R6
STESX13.070.04
+0.31%
Bernstein International Strat Eqs SCB
GIRGX22.92N/A
N/A
Goldman Sachs U.S. Equity ESG Inv
BCSKX8.75N/A
N/A
BlackRock Commodity Strategies K

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.80%
IONS - ALNY
48%
Loosely correlated
-4.12%
ATRA - ALNY
44%
Loosely correlated
-0.66%
SGMO - ALNY
42%
Loosely correlated
+0.51%
AMLX - ALNY
40%
Loosely correlated
-0.76%
VXRT - ALNY
40%
Loosely correlated
-1.40%
More

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-12.15%
MDGL - GHRS
43%
Loosely correlated
+3.83%
IBRX - GHRS
31%
Poorly correlated
+3.28%
ORMP - GHRS
31%
Poorly correlated
+2.21%
CYTK - GHRS
30%
Poorly correlated
-4.39%
ALNY - GHRS
29%
Poorly correlated
-0.80%
More